HANDBOOK OF GENERAL MEDICINE VOL 1:@0.076190:0.972666:0.349932:0.972666:0.349932:0.958637:0.076190:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
158:@0.078769:0.033217:0.109813:0.033217:0.109813:0.013052:0.078769:0.013052:0.010348:0.010348:0.010348
TREATMENT AppROACHEs:@0.397030:0.032906:0.624375:0.032906:0.624375:0.013617:0.397030:0.013617:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
larging hilar or paratracheal lymphadenopathy, or the :@0.076190:0.363701:0.485160:0.363701:0.485160:0.347918:0.076190:0.347918:0.002873:0.010175:0.004400:0.010024:0.002873:0.009071:0.010024:0.006426:0.009071:0.002873:0.002873:0.010175:0.004400:0.006426:0.009752:0.004400:0.006426:0.010160:0.010175:0.004400:0.010175:0.004974:0.004400:0.010175:0.009631:0.009071:0.009676:0.010175:0.002873:0.006426:0.002873:0.007953:0.014030:0.010160:0.009071:0.010175:0.010205:0.009676:0.009071:0.009752:0.010160:0.010175:0.004974:0.009071:0.007953:0.004037:0.006426:0.009752:0.004400:0.006426:0.004974:0.009071:0.009827:0.004188
development of new nodules or worsening infiltrates. :@0.076190:0.378144:0.458037:0.378144:0.458037:0.362361:0.076190:0.362361:0.010205:0.009676:0.008225:0.009676:0.002873:0.009752:0.010160:0.014030:0.009676:0.009071:0.004974:0.004037:0.009752:0.004596:0.004037:0.009071:0.009676:0.012413:0.004037:0.009071:0.009752:0.010205:0.009041:0.002873:0.009676:0.005715:0.004037:0.009752:0.004400:0.004037:0.012413:0.009752:0.004400:0.005715:0.009676:0.009071:0.002873:0.009071:0.010024:0.004037:0.002873:0.009071:0.003606:0.003606:0.002873:0.004974:0.004400:0.010175:0.004974:0.009676:0.005715:0.004188:0.004188
Central nervous system involvement typically  takes :@0.090478:0.392587:0.485145:0.392587:0.485145:0.376805:0.090478:0.376805:0.012292:0.009827:0.009223:0.005125:0.004551:0.010326:0.003024:0.008104:0.009223:0.009827:0.004551:0.008376:0.009903:0.009192:0.005866:0.008104:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.008104:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.008104:0.005125:0.008104:0.010311:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.004188:0.003931:0.005125:0.010326:0.007590:0.009827:0.005866:0.004188
one of two forms: TB meningitis or intracerebral tuber-:@0.076190:0.407031:0.480942:0.407031:0.480942:0.391248:0.076190:0.391248:0.009903:0.009223:0.009827:0.006169:0.009903:0.004747:0.006169:0.005125:0.012564:0.009903:0.006169:0.004747:0.009903:0.004551:0.014182:0.005866:0.004188:0.006169:0.006441:0.008678:0.006184:0.014182:0.009827:0.009223:0.003024:0.009223:0.010175:0.003024:0.005125:0.003024:0.005866:0.006184:0.009903:0.004551:0.006169:0.003024:0.009223:0.005125:0.004551:0.010326:0.009782:0.009827:0.004551:0.009827:0.010311:0.004551:0.010326:0.003024:0.006169:0.005125:0.009192:0.010311:0.009827:0.004551:0.005020
culomas. Interestingly, in one study, patients who later :@0.076190:0.421474:0.485145:0.421474:0.485145:0.405692:0.076190:0.405692:0.009782:0.009192:0.003024:0.009903:0.014182:0.010326:0.005866:0.004188:0.005745:0.003417:0.009223:0.005125:0.009827:0.004551:0.009827:0.005866:0.005125:0.003024:0.009223:0.010175:0.003024:0.008104:0.004188:0.005730:0.003024:0.009223:0.005745:0.009903:0.009223:0.009827:0.005745:0.005866:0.005125:0.009192:0.010357:0.008104:0.004188:0.005745:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005745:0.012564:0.009223:0.009903:0.005745:0.003024:0.010326:0.005125:0.009827:0.004551:0.004188
developed a paradoxical TB  meningitis had  IRIs with :@0.076190:0.435918:0.485145:0.435918:0.485145:0.420135:0.076190:0.420135:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.009827:0.010357:0.007469:0.010326:0.007469:0.010311:0.010326:0.004551:0.010326:0.010357:0.009903:0.007257:0.003024:0.009782:0.010326:0.003024:0.007469:0.006441:0.008678:0.004188:0.003266:0.014182:0.009827:0.009223:0.003024:0.009223:0.010175:0.003024:0.005125:0.003024:0.005866:0.007469:0.009223:0.010326:0.010357:0.004188:0.003266:0.003417:0.009177:0.003417:0.007529:0.007469:0.012564:0.003024:0.005125:0.009223:0.004188
significantly  higher  baseline  cerebrospinal  fluid  (CSF), :@0.076190:0.450361:0.485145:0.450361:0.485145:0.434578:0.076190:0.434578:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.003024:0.008104:0.004188:0.003840:0.009223:0.003024:0.010175:0.009223:0.009827:0.004551:0.004188:0.003825:0.010311:0.010326:0.005866:0.009827:0.003024:0.003024:0.009223:0.009827:0.004188:0.003840:0.009782:0.009827:0.004551:0.009827:0.010311:0.004551:0.009903:0.005866:0.010311:0.003024:0.009223:0.010326:0.003024:0.004188:0.003840:0.003666:0.003666:0.009192:0.003024:0.010357:0.004188:0.003840:0.005579:0.012292:0.007529:0.007333:0.005579:0.004188:0.004188
neutrophil  counts and lower CsF glucose levels than :@0.076190:0.464804:0.485160:0.464804:0.485160:0.449022:0.076190:0.449022:0.009223:0.009827:0.009192:0.005125:0.004551:0.009903:0.010311:0.009223:0.003024:0.003024:0.004188:0.003477:0.009782:0.009903:0.009192:0.009223:0.005125:0.005866:0.007680:0.010326:0.009223:0.010357:0.007680:0.003024:0.009903:0.012564:0.009827:0.004551:0.007680:0.012292:0.007529:0.007333:0.007680:0.010175:0.003024:0.009192:0.009782:0.009903:0.005866:0.009827:0.007680:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.007680:0.005125:0.009223:0.010326:0.009223:0.004188
those who did not develop TB meningitis IRIs.  Because :@0.076190:0.479248:0.485131:0.479204:0.485131:0.463422:0.076190:0.463465:0.005125:0.009223:0.009903:0.005866:0.009827:0.004339:0.012564:0.009223:0.009903:0.004339:0.010357:0.003024:0.010357:0.004354:0.009223:0.009903:0.005125:0.004339:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.004354:0.006441:0.008678:0.004339:0.014182:0.009827:0.009223:0.003024:0.009223:0.010175:0.003024:0.005125:0.003024:0.005866:0.004339:0.003417:0.009177:0.003417:0.007529:0.004188:0.009722:0.004339:0.008678:0.009827:0.009782:0.010326:0.009192:0.005866:0.009827:0.221719
10:@0.403384:0.473906:0.413100:0.473906:0.413100:0.464752:0.403384:0.464752:0.004858:0.004858
of its location, IRIs within the nervous system is far more :@0.076191:0.493648:0.485161:0.493648:0.485161:0.477865:0.076191:0.477865:0.009903:0.004747:0.004883:0.003024:0.005125:0.005866:0.004883:0.003024:0.009903:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004883:0.003417:0.009177:0.003417:0.007529:0.004883:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004883:0.005125:0.009223:0.009827:0.004883:0.009223:0.009827:0.004551:0.008376:0.009903:0.009192:0.005866:0.004883:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.004883:0.003024:0.005866:0.004883:0.004747:0.010326:0.004551:0.004883:0.014182:0.009903:0.004551:0.009827:0.004188
likely to result in permanent disability or death than IRIs :@0.076191:0.508091:0.485131:0.508091:0.485131:0.492309:0.076191:0.492309:0.003024:0.003024:0.007590:0.009827:0.003024:0.008104:0.004868:0.005125:0.009903:0.004868:0.004551:0.009827:0.005866:0.009192:0.003024:0.005125:0.004868:0.003024:0.009223:0.004868:0.010311:0.009827:0.004551:0.014182:0.010326:0.009223:0.009827:0.009223:0.005125:0.004853:0.010357:0.003024:0.005866:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004883:0.009903:0.004551:0.004853:0.010357:0.009827:0.010326:0.005125:0.009223:0.004853:0.005125:0.009223:0.010326:0.009223:0.004853:0.003417:0.009177:0.003417:0.007529:0.004188
elsewhere in the body.:@0.076191:0.522535:0.242576:0.522535:0.242576:0.506752:0.076191:0.506752:0.009827:0.003024:0.005866:0.009827:0.012564:0.009223:0.009827:0.004551:0.009827:0.004188:0.003024:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.010311:0.009903:0.010357:0.008104:0.004188
5:@0.242559:0.517220:0.247417:0.517220:0.247417:0.508066:0.242559:0.508066:0.004858
Abdominal TB IRIs may result in (or can exacerbate) he-:@0.090476:0.536956:0.480925:0.536956:0.480925:0.521174:0.090476:0.521174:0.011037:0.010160:0.010205:0.009752:0.014030:0.002873:0.009071:0.010175:0.002873:0.003160:0.006290:0.008527:0.003160:0.003266:0.009026:0.003266:0.007378:0.003160:0.014030:0.010175:0.007953:0.003160:0.004400:0.009676:0.005715:0.009041:0.002873:0.004974:0.003160:0.002873:0.009071:0.003160:0.005428:0.009752:0.004400:0.003160:0.009631:0.010175:0.009071:0.003160:0.009676:0.007106:0.010175:0.009631:0.009676:0.004400:0.010160:0.010175:0.004974:0.009676:0.005428:0.003160:0.009071:0.009676:0.005020
patomegaly, splenomegaly, abdominal lymphadeno-:@0.076189:0.551400:0.480955:0.551400:0.480955:0.535617:0.076189:0.535617:0.010160:0.010175:0.004974:0.009752:0.014030:0.009676:0.010024:0.010175:0.002873:0.007953:0.004037:0.009207:0.005715:0.010160:0.002873:0.009676:0.009071:0.009752:0.014030:0.009676:0.010024:0.010175:0.002873:0.007953:0.004037:0.009207:0.010175:0.010160:0.010205:0.009752:0.014030:0.002873:0.009071:0.010175:0.002873:0.009207:0.002873:0.007953:0.014030:0.010160:0.009071:0.010175:0.010205:0.009676:0.009071:0.009752:0.005020
pathy or ascites. With hepatic involvement, the typical :@0.076189:0.565843:0.485143:0.565843:0.485143:0.550061:0.076189:0.550061:0.010160:0.010175:0.004974:0.009071:0.007953:0.006093:0.009752:0.004400:0.006093:0.010175:0.005715:0.009631:0.002873:0.004974:0.009676:0.005715:0.004037:0.006093:0.014363:0.002873:0.004974:0.009071:0.006093:0.009071:0.009676:0.010160:0.010175:0.004974:0.002873:0.009631:0.006093:0.002873:0.009071:0.008225:0.009752:0.002873:0.008225:0.009676:0.014030:0.009676:0.009071:0.004974:0.004037:0.006093:0.004974:0.009071:0.009676:0.006093:0.004974:0.007953:0.010160:0.002873:0.009631:0.010175:0.003024:0.004188
pattern seen on liver-function tests is that of cholestasis :@0.076189:0.580287:0.485128:0.580287:0.485128:0.564504:0.076189:0.564504:0.010160:0.010175:0.004974:0.004974:0.009676:0.004400:0.009071:0.005866:0.005715:0.009676:0.009676:0.009071:0.005866:0.009752:0.009071:0.005866:0.002873:0.002873:0.008225:0.009676:0.004400:0.004868:0.004596:0.009041:0.009071:0.009631:0.004974:0.002873:0.009752:0.009071:0.005866:0.004974:0.009676:0.005715:0.004974:0.005715:0.005866:0.002873:0.005715:0.005866:0.004974:0.009071:0.010175:0.004974:0.005866:0.009752:0.004596:0.005866:0.009631:0.009071:0.009752:0.002873:0.009676:0.005715:0.004974:0.010175:0.005715:0.002873:0.005866:0.004188
(i.e. disproportionately high alkaline phosphatase and :@0.076189:0.594730:0.485158:0.594730:0.485158:0.578947:0.076189:0.578947:0.005428:0.002873:0.004037:0.009676:0.004037:0.007711:0.010205:0.002873:0.005715:0.010160:0.004400:0.009752:0.010160:0.009752:0.004400:0.004974:0.002873:0.009752:0.009071:0.010175:0.004974:0.009676:0.002873:0.007953:0.007711:0.009071:0.002873:0.010024:0.009071:0.007711:0.010175:0.002873:0.007439:0.010175:0.002873:0.002873:0.009071:0.009676:0.007711:0.010160:0.009071:0.009752:0.005715:0.010160:0.009071:0.010175:0.004974:0.010175:0.005715:0.009676:0.007711:0.010175:0.009071:0.010357:0.004188
gamma-glutamyl transferase), rather than the transami-:@0.519040:0.084952:0.923792:0.084952:0.923792:0.069170:0.519040:0.069170:0.010024:0.010175:0.014030:0.014030:0.010175:0.004868:0.010024:0.002873:0.009041:0.004974:0.010175:0.014030:0.007953:0.002873:0.005065:0.004974:0.004400:0.010175:0.009071:0.005715:0.004596:0.009676:0.004400:0.010175:0.005715:0.009676:0.005428:0.004037:0.005065:0.004400:0.010175:0.004974:0.009071:0.009676:0.004400:0.005065:0.004974:0.009071:0.010175:0.009071:0.005065:0.004974:0.009071:0.009676:0.005065:0.004974:0.004400:0.010175:0.009071:0.005715:0.010175:0.014030:0.002873:0.005020
nitis than is typical of drug-induced liver injuries. :@0.519040:0.099338:0.859899:0.099338:0.859899:0.083555:0.519040:0.083555:0.009071:0.002873:0.004974:0.002873:0.005715:0.004037:0.004974:0.009071:0.010175:0.009071:0.004037:0.002873:0.005715:0.004037:0.004974:0.007953:0.010160:0.002873:0.009631:0.010175:0.002873:0.004037:0.009752:0.004596:0.004037:0.010205:0.004400:0.009041:0.010024:0.004868:0.002873:0.009071:0.010205:0.009041:0.009631:0.009676:0.010205:0.004037:0.002873:0.002873:0.008225:0.009676:0.004400:0.004037:0.002873:0.009071:0.002918:0.009041:0.004400:0.002873:0.009676:0.005715:0.004188:0.004188
TB IRIs manifestations are frequently accompanied by :@0.533328:0.113723:0.927995:0.113723:0.927995:0.097941:0.533328:0.097941:0.006441:0.008678:0.003659:0.003417:0.009177:0.003417:0.007529:0.003659:0.014182:0.010326:0.009223:0.003024:0.004747:0.009827:0.005866:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.003659:0.010326:0.004551:0.009827:0.003659:0.004747:0.004551:0.009827:0.010311:0.009192:0.009827:0.009223:0.005125:0.003024:0.008104:0.003644:0.010326:0.009782:0.009782:0.009903:0.014182:0.010311:0.010326:0.009223:0.003024:0.009827:0.010357:0.003659:0.010311:0.008104:0.004188
fevers, weight loss, night sweats and/or loss of appetite. :@0.519040:0.128109:0.927995:0.128109:0.927995:0.112326:0.519040:0.112326:0.004747:0.009827:0.008376:0.009827:0.004551:0.005866:0.004188:0.004233:0.012564:0.009827:0.003024:0.010175:0.009223:0.005125:0.004233:0.003024:0.009903:0.005866:0.005866:0.004188:0.004248:0.009223:0.003024:0.010175:0.009223:0.005125:0.004233:0.005866:0.012564:0.009827:0.010326:0.005125:0.005866:0.004248:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.004233:0.003024:0.009903:0.005866:0.005866:0.004248:0.009903:0.004747:0.004233:0.010326:0.010311:0.010311:0.009827:0.005125:0.003024:0.005125:0.009827:0.004188:0.004188
Occasionally, these symptoms may be the only mani-:@0.519040:0.142495:0.923777:0.142495:0.923777:0.126712:0.519040:0.126712:0.013138:0.009782:0.009782:0.010326:0.005866:0.003024:0.009903:0.009223:0.010326:0.003024:0.003024:0.008104:0.004188:0.006108:0.005125:0.009223:0.009827:0.005866:0.009827:0.006093:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.006093:0.014182:0.010326:0.008104:0.006093:0.010311:0.009827:0.006093:0.005125:0.009223:0.009827:0.006093:0.009903:0.009223:0.003024:0.008104:0.006093:0.014182:0.010326:0.009223:0.003024:0.005020
festation of TB IRIs.:@0.519040:0.156880:0.652269:0.156880:0.652269:0.141098:0.519040:0.141098:0.004747:0.009827:0.005866:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.009903:0.004747:0.004188:0.006441:0.008678:0.004188:0.003417:0.009177:0.003417:0.007529:0.004188
11:@0.652262:0.151581:0.661978:0.151581:0.661978:0.142428:0.652262:0.142428:0.004858:0.004858
DiAGnOsis:@0.519047:0.190017:0.619942:0.190017:0.619942:0.169852:0.519047:0.169852:0.012935:0.005174:0.013674:0.015522:0.013674:0.015522:0.009609:0.005174:0.009609
There is no commercially available test for IRIs. Instead, :@0.519047:0.206185:0.927987:0.206185:0.927987:0.190402:0.519047:0.190402:0.006441:0.009223:0.009827:0.004551:0.009827:0.004657:0.003024:0.005866:0.004687:0.009223:0.009903:0.004672:0.009782:0.009903:0.014182:0.014182:0.009827:0.004551:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.004672:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004687:0.005125:0.009827:0.005866:0.005125:0.004672:0.004747:0.009903:0.004551:0.004672:0.003417:0.009177:0.003417:0.007529:0.004188:0.004672:0.003417:0.009223:0.005866:0.005125:0.009827:0.010326:0.010357:0.004188:0.004188
identifying the syndrome rests on several key data :@0.519047:0.220570:0.927987:0.220570:0.927987:0.204788:0.519047:0.204788:0.003024:0.010357:0.009827:0.009223:0.005125:0.003024:0.004747:0.008104:0.003024:0.009223:0.010175:0.009842:0.005125:0.009223:0.009827:0.009842:0.005866:0.008104:0.009223:0.010357:0.004551:0.009903:0.014182:0.009827:0.009842:0.004551:0.009827:0.005866:0.005125:0.005866:0.009842:0.009903:0.009223:0.009842:0.005866:0.009827:0.008376:0.009827:0.004551:0.010326:0.003024:0.009842:0.007590:0.009827:0.008104:0.009842:0.010357:0.010326:0.005125:0.010326:0.004188
points::@0.519047:0.234956:0.566687:0.234956:0.566687:0.219173:0.519047:0.219173:0.010311:0.009903:0.003024:0.009223:0.005125:0.005866:0.004188
1.  signs and symptoms compatible with TB, and in the :@0.519047:0.249342:0.928032:0.249342:0.928032:0.233559:0.519047:0.233559:0.008376:0.004188:0.004188:0.008452:0.007529:0.003024:0.010175:0.009223:0.005866:0.004868:0.010326:0.009223:0.010357:0.004868:0.005866:0.008104:0.014182:0.010311:0.005125:0.009903:0.014182:0.005866:0.004868:0.009782:0.009903:0.014182:0.010311:0.010326:0.005125:0.003024:0.010311:0.003024:0.009827:0.004868:0.012564:0.003024:0.005125:0.009223:0.004868:0.006441:0.008678:0.004188:0.004868:0.010326:0.009223:0.010357:0.004868:0.003024:0.009223:0.004868:0.005125:0.009223:0.009827:0.004188
case of paradoxical TB IRIs, worsening of TB symp-:@0.544251:0.263727:0.923799:0.263727:0.923799:0.247945:0.544251:0.247945:0.009782:0.010326:0.005866:0.009827:0.006184:0.009903:0.004747:0.006184:0.010311:0.010326:0.004551:0.010326:0.010357:0.009903:0.007257:0.003024:0.009782:0.010326:0.003024:0.006184:0.006441:0.008678:0.006184:0.003417:0.009177:0.003417:0.007529:0.004188:0.006184:0.012564:0.009903:0.004551:0.005866:0.009827:0.009223:0.003024:0.009223:0.010175:0.006169:0.009903:0.004747:0.006184:0.006441:0.008678:0.006184:0.005866:0.008104:0.014182:0.010311:0.005020
toms after initial improvement.:@0.544251:0.278113:0.765956:0.278113:0.765956:0.262330:0.544251:0.262330:0.005125:0.009903:0.014182:0.005866:0.004188:0.010326:0.004747:0.005125:0.009827:0.004551:0.004188:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.003024:0.004188:0.003024:0.014182:0.010311:0.004551:0.009903:0.008376:0.009827:0.014182:0.009827:0.009223:0.005125:0.004188
2.  A temporal association with ART – generally within :@0.519047:0.292499:0.928002:0.292499:0.928002:0.276716:0.519047:0.276716:0.008376:0.004188:0.004188:0.008452:0.011188:0.006305:0.005125:0.009827:0.014182:0.010311:0.009903:0.004551:0.010326:0.003024:0.006305:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.006320:0.012564:0.003024:0.005125:0.009223:0.006320:0.011188:0.009177:0.006441:0.006305:0.007560:0.006320:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.003024:0.008104:0.006320:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188
the first three months – and ideally associated with :@0.544251:0.306884:0.927987:0.306884:0.927987:0.291102:0.544251:0.291102:0.005125:0.009223:0.009827:0.005609:0.003681:0.003681:0.004551:0.005866:0.005125:0.005609:0.005125:0.009223:0.004551:0.009827:0.009827:0.005609:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.005609:0.007560:0.005609:0.010326:0.009223:0.010357:0.005609:0.003024:0.010357:0.009827:0.010326:0.003024:0.003024:0.008104:0.005624:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.005624:0.012564:0.003024:0.005125:0.009223:0.004188
a  significant  change  in  HIV  viral  load  and/or  CD4 :@0.544251:0.321270:0.927987:0.321270:0.927987:0.305487:0.544251:0.305487:0.010326:0.004188:0.002706:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.004188:0.002706:0.009782:0.009223:0.010326:0.009223:0.010175:0.009827:0.004188:0.002691:0.003024:0.009223:0.004188:0.002706:0.010326:0.003417:0.010614:0.004188:0.002706:0.008376:0.003024:0.004551:0.010326:0.003024:0.004188:0.002706:0.003024:0.009903:0.010326:0.010357:0.004188:0.002706:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.004188:0.002706:0.012292:0.011249:0.008376:0.004188
count over that period.:@0.544251:0.335655:0.714657:0.335655:0.714657:0.319873:0.544251:0.319873:0.009782:0.009903:0.009192:0.009223:0.005125:0.004188:0.009903:0.008376:0.009827:0.004551:0.004188:0.005125:0.009223:0.010326:0.005125:0.004188:0.010311:0.009827:0.004551:0.003024:0.009903:0.010357:0.004188
3.  Exclusion of other possible causes of clinical deterio-:@0.519047:0.350041:0.923814:0.350041:0.923814:0.334258:0.519047:0.334258:0.008376:0.004188:0.004188:0.008452:0.008104:0.007257:0.009782:0.003024:0.009192:0.005866:0.003024:0.009903:0.009223:0.004067:0.009903:0.004747:0.004052:0.009903:0.005125:0.009223:0.009827:0.004551:0.004052:0.010311:0.009903:0.005866:0.005866:0.003024:0.010311:0.003024:0.009827:0.004067:0.009782:0.010326:0.009192:0.005866:0.009827:0.005866:0.004067:0.009903:0.004747:0.004052:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004067:0.010357:0.009827:0.005125:0.009827:0.004551:0.003024:0.009903:0.005020
ration.:@0.544251:0.364427:0.590590:0.364427:0.590590:0.348644:0.544251:0.348644:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
Over the years, several groups of authors  have put :@0.533335:0.378812:0.928002:0.378812:0.928002:0.363030:0.533335:0.363030:0.013138:0.008376:0.009827:0.004551:0.006819:0.005125:0.009223:0.009827:0.006819:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.006819:0.005866:0.009827:0.008376:0.009827:0.004551:0.010326:0.003024:0.006819:0.010175:0.004551:0.009903:0.009192:0.010311:0.005866:0.006819:0.009903:0.004747:0.006819:0.010326:0.009192:0.005125:0.009223:0.009903:0.004551:0.005866:0.004188:0.002616:0.009223:0.010326:0.008376:0.009827:0.006819:0.010311:0.009192:0.005125:0.004188
together a variety of different case definitions for both :@0.519047:0.393198:0.928002:0.393198:0.928002:0.377415:0.519047:0.377415:0.005125:0.009903:0.010175:0.009827:0.005125:0.009223:0.009827:0.004551:0.005337:0.010326:0.005352:0.008376:0.010326:0.004551:0.003024:0.009827:0.005125:0.008104:0.005352:0.009903:0.004747:0.005352:0.010357:0.003024:0.004747:0.004747:0.009827:0.004551:0.009827:0.009223:0.005125:0.005337:0.009782:0.010326:0.005866:0.009827:0.005352:0.010357:0.009827:0.003681:0.003681:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.005866:0.005352:0.004747:0.009903:0.004551:0.005337:0.010311:0.009903:0.005125:0.009223:0.004188
IRIS in general and for TB IRIS specifically. One example :@0.519047:0.407584:0.928002:0.407584:0.928002:0.391801:0.519047:0.391801:0.003417:0.009177:0.003417:0.007529:0.004747:0.003024:0.009223:0.004747:0.010175:0.009827:0.009223:0.009827:0.004551:0.010326:0.003024:0.004732:0.010326:0.009223:0.010357:0.004747:0.004747:0.009903:0.004551:0.004732:0.006441:0.008678:0.004747:0.003417:0.009177:0.003417:0.007529:0.004747:0.005866:0.010311:0.009827:0.009782:0.003024:0.003681:0.003681:0.009782:0.010326:0.003024:0.003024:0.008104:0.004188:0.004747:0.013138:0.009223:0.009827:0.004747:0.009827:0.007257:0.010326:0.014182:0.010311:0.003024:0.009827:0.004188
from each group is outlined in Table 1. These definitions :@0.519047:0.421969:0.927987:0.421969:0.927987:0.406187:0.519047:0.406187:0.004747:0.004551:0.009903:0.014182:0.004505:0.009827:0.010326:0.009782:0.009223:0.004521:0.010175:0.004551:0.009903:0.009177:0.010311:0.004521:0.003024:0.005866:0.004521:0.009903:0.009192:0.005125:0.003024:0.003024:0.009223:0.009827:0.010357:0.004521:0.003024:0.009223:0.004521:0.006441:0.010326:0.010311:0.003024:0.009827:0.004521:0.008376:0.004188:0.004521:0.006441:0.009223:0.009827:0.005866:0.009827:0.004521:0.010357:0.009827:0.003681:0.003681:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188
were developed primarily to define groups for research :@0.519047:0.436355:0.927987:0.436355:0.927987:0.420572:0.519047:0.420572:0.012564:0.009827:0.004551:0.009827:0.004324:0.010357:0.009827:0.008376:0.009827:0.003024:0.009903:0.010311:0.009827:0.010357:0.004339:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.003024:0.003024:0.008104:0.004339:0.005125:0.009903:0.004324:0.010357:0.009827:0.003681:0.003681:0.009223:0.009827:0.004324:0.010175:0.004551:0.009903:0.009192:0.010311:0.005866:0.004324:0.004747:0.009903:0.004551:0.004324:0.004551:0.009827:0.005866:0.009827:0.010326:0.004551:0.009782:0.009223:0.004188
purposes  clearly,  but  they  may also be  used  for  clini-:@0.519047:0.450740:0.923784:0.450740:0.923784:0.434958:0.519047:0.434958:0.010311:0.009192:0.004551:0.010311:0.009903:0.005866:0.009827:0.005866:0.004188:0.002449:0.009782:0.003024:0.009827:0.010326:0.004551:0.003024:0.008104:0.004188:0.004188:0.002449:0.010311:0.009192:0.005125:0.004188:0.002449:0.005125:0.009223:0.009827:0.008104:0.004188:0.002449:0.014182:0.010326:0.008104:0.006652:0.010326:0.003024:0.005866:0.009903:0.006652:0.010311:0.009827:0.004188:0.002449:0.009192:0.005866:0.009827:0.010357:0.004188:0.002449:0.004747:0.009903:0.004551:0.004188:0.002449:0.009782:0.003024:0.003024:0.009223:0.003024:0.005020
cal  diagnosis.  The  case  definition  that  is  most  used  in :@0.519047:0.465126:0.927987:0.465126:0.927987:0.449343:0.519047:0.449343:0.009782:0.010326:0.003024:0.004188:0.002495:0.010357:0.003024:0.010326:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188:0.004188:0.002480:0.006441:0.009223:0.009827:0.004188:0.002480:0.009782:0.010326:0.005866:0.009827:0.004188:0.002495:0.010357:0.009827:0.003681:0.003681:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.002480:0.005125:0.009223:0.010326:0.005125:0.004188:0.002480:0.003024:0.005866:0.004188:0.002495:0.014182:0.009903:0.005866:0.005125:0.004188:0.002480:0.009192:0.005866:0.009827:0.010357:0.004188:0.002480:0.003024:0.009223:0.004188
limited-resource settings is that of Meintjes :@0.519047:0.479512:0.835201:0.479512:0.835201:0.463729:0.519047:0.463729:0.003024:0.003024:0.014182:0.003024:0.005125:0.009827:0.010357:0.005020:0.004551:0.009827:0.005866:0.009903:0.009192:0.004551:0.009782:0.009827:0.005488:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.005866:0.005488:0.003024:0.005866:0.005503:0.005125:0.009223:0.010326:0.005125:0.005488:0.009903:0.004747:0.005488:0.013894:0.009827:0.003024:0.009223:0.005125:0.003069:0.009827:0.005866:0.004188
et al:@0.836517:0.479512:0.870308:0.479512:0.870308:0.463729:0.836517:0.463729:0.009827:0.005125:0.005488:0.010326:0.003024
, which :@0.870308:0.479512:0.927987:0.479512:0.927987:0.463729:0.870308:0.463729:0.004188:0.005488:0.012564:0.009223:0.003024:0.009782:0.009223:0.004188
benefits from clear and clinically relevant criteria.:@0.519047:0.493897:0.877308:0.493897:0.877308:0.478115:0.519047:0.478115:0.010311:0.009827:0.009223:0.009827:0.003681:0.003681:0.005125:0.005866:0.003810:0.004747:0.004551:0.009903:0.014182:0.003810:0.009782:0.003024:0.009827:0.010326:0.004551:0.003825:0.010326:0.009223:0.010357:0.003825:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.003024:0.008104:0.003825:0.004551:0.009827:0.003024:0.009827:0.008376:0.010326:0.009223:0.005125:0.003810:0.009782:0.004551:0.003024:0.005125:0.009827:0.004551:0.003024:0.010326:0.004188
9:@0.877317:0.488681:0.882175:0.488681:0.882175:0.479527:0.877317:0.479527:0.004858
 How-:@0.882177:0.493980:0.923814:0.493980:0.923814:0.478197:0.882177:0.478197:0.003825:0.010326:0.009903:0.012564:0.005020
ever,  disadvantages  of  this  case  definition  include  its :@0.519047:0.508366:0.927987:0.508366:0.927987:0.492583:0.519047:0.492583:0.009827:0.008376:0.009827:0.004551:0.004188:0.004188:0.002888:0.010357:0.003024:0.005866:0.010326:0.010357:0.008376:0.010326:0.009238:0.005125:0.010326:0.010175:0.009827:0.005866:0.004188:0.002903:0.009903:0.004747:0.004188:0.002888:0.005125:0.009223:0.003024:0.005866:0.004188:0.002903:0.009782:0.010326:0.005866:0.009827:0.004188:0.002903:0.010357:0.009827:0.003681:0.003681:0.009223:0.003024:0.005125:0.003024:0.009903:0.009223:0.004188:0.002888:0.003024:0.009223:0.009782:0.003024:0.009192:0.010357:0.009827:0.004188:0.002903:0.003024:0.005125:0.005866:0.004188
limitation to paradoxical TB IRIs cases (rather than un-:@0.519047:0.522751:0.923814:0.522751:0.923814:0.506969:0.519047:0.506969:0.003024:0.003024:0.014182:0.003024:0.005125:0.010326:0.005125:0.003024:0.009903:0.009223:0.005972:0.005125:0.009903:0.005957:0.010311:0.010326:0.004551:0.010326:0.010357:0.009903:0.007257:0.003024:0.009782:0.010326:0.003024:0.005972:0.006441:0.008678:0.005972:0.003417:0.009177:0.003417:0.007529:0.005972:0.009782:0.010326:0.005866:0.009827:0.005866:0.005972:0.005579:0.004551:0.010326:0.005125:0.009223:0.009827:0.004551:0.005957:0.005125:0.009223:0.010326:0.009223:0.005957:0.009192:0.009223:0.005020
masking TB IRIs cases) and the lack of any CD4 or HIV :@0.519047:0.537137:0.927987:0.537137:0.927987:0.521354:0.519047:0.521354:0.014182:0.010326:0.005866:0.007590:0.003024:0.009223:0.010175:0.005518:0.006441:0.008678:0.005503:0.003417:0.009177:0.003417:0.007529:0.005503:0.009782:0.010326:0.005866:0.009827:0.005866:0.005579:0.005518:0.010326:0.009223:0.010357:0.005518:0.005125:0.009223:0.009827:0.005503:0.003024:0.010326:0.009782:0.007590:0.005518:0.009903:0.004747:0.005503:0.010326:0.009223:0.008104:0.005518:0.012292:0.011249:0.008376:0.005518:0.009903:0.004551:0.005503:0.010326:0.003417:0.010614:0.004188
viral load criteria. The latter may be helpful in the clinical :@0.519047:0.551522:0.927987:0.551522:0.927987:0.535740:0.519047:0.535740:0.008376:0.003024:0.004551:0.010326:0.003024:0.003432:0.003024:0.009903:0.010326:0.010357:0.003432:0.009782:0.004551:0.003024:0.005125:0.009827:0.004551:0.003024:0.010326:0.004188:0.003417:0.006441:0.009223:0.009827:0.003417:0.003024:0.010326:0.005125:0.005125:0.009827:0.004551:0.003417:0.014182:0.010326:0.008104:0.003432:0.010311:0.009827:0.003417:0.009223:0.009827:0.003024:0.010311:0.004747:0.009192:0.003024:0.003432:0.003024:0.009223:0.003432:0.005125:0.009223:0.009827:0.003417:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004188
setting. TB IRIs is extremely unlikely without a substantial :@0.519047:0.565908:0.927987:0.565908:0.927987:0.550125:0.519047:0.550125:0.005866:0.009827:0.005125:0.005125:0.003024:0.009223:0.010175:0.004188:0.004747:0.006441:0.008678:0.004747:0.003417:0.009177:0.003417:0.007529:0.004762:0.003024:0.005866:0.004762:0.009827:0.007257:0.005125:0.004551:0.009827:0.014182:0.009827:0.003024:0.008104:0.004747:0.009192:0.009223:0.003024:0.003024:0.007590:0.009827:0.003024:0.008104:0.004762:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.004747:0.010326:0.004747:0.005866:0.009192:0.010311:0.005866:0.005125:0.010326:0.009223:0.005125:0.003024:0.010326:0.003024:0.004188
decrease in baseline viral load and/or a substantial in-:@0.519047:0.580294:0.923799:0.580294:0.923799:0.564511:0.519047:0.564511:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005231:0.003024:0.009223:0.005231:0.010311:0.010326:0.005866:0.009827:0.003024:0.003024:0.009223:0.009827:0.005231:0.008376:0.003024:0.004551:0.010326:0.003024:0.005231:0.003024:0.009903:0.010326:0.010357:0.005231:0.010326:0.009223:0.010357:0.006607:0.009903:0.004551:0.005216:0.010326:0.005231:0.005866:0.009192:0.010311:0.005866:0.005125:0.010326:0.009223:0.005125:0.003024:0.010326:0.003024:0.005231:0.003024:0.009223:0.005020
crease in CD4+ T cells from baseline (though the latter :@0.519047:0.594679:0.927987:0.594679:0.927987:0.578897:0.519047:0.578897:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.005322:0.003024:0.009223:0.005322:0.012292:0.011249:0.008376:0.009162:0.005322:0.006441:0.005322:0.009782:0.009827:0.003024:0.003024:0.005866:0.005337:0.004747:0.004551:0.009903:0.014182:0.005322:0.010311:0.010326:0.005866:0.009827:0.003024:0.003024:0.009223:0.009827:0.005322:0.005579:0.005125:0.009223:0.009903:0.009192:0.010175:0.009223:0.005307:0.005125:0.009223:0.009827:0.005322:0.003024:0.010326:0.005125:0.005125:0.009827:0.004551:0.004188
figure 1. A patient with paradoxical tb iris involving:@0.076190:0.317319:0.454771:0.317319:0.454771:0.300821:0.076190:0.300821:0.007257:0.003629:0.009979:0.009071:0.004838:0.009676:0.004233:0.008467:0.004233:0.004233:0.011188:0.004233:0.009979:0.009979:0.004536:0.003629:0.009676:0.009071:0.004536:0.004233:0.012095:0.003629:0.004536:0.009071:0.004233:0.009979:0.009979:0.004838:0.009979:0.009979:0.009676:0.008467:0.003629:0.009676:0.009979:0.003629:0.004233:0.006350:0.008769:0.004233:0.004233:0.008769:0.004233:0.007862:0.004233:0.003629:0.009071:0.008467:0.009676:0.003629:0.008467:0.003629:0.009071:0.009979
the cervical lymph nodes:@0.076190:0.331428:0.262457:0.331428:0.262457:0.314929:0.076190:0.314929:0.004536:0.009071:0.009676:0.004233:0.009676:0.009676:0.004838:0.008467:0.003629:0.009676:0.009979:0.003629:0.004233:0.003629:0.008769:0.014212:0.009979:0.009071:0.004233:0.009071:0.009676:0.009979:0.009676:0.006652
Table 1. Examples of case definitions for IRIS in general and for TB IRIS:@0.077030:0.628489:0.579889:0.628489:0.579889:0.611990:0.077030:0.611990:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.007862:0.008467:0.009979:0.014212:0.009979:0.003629:0.009676:0.006652:0.004233:0.009676:0.004233:0.004233:0.009676:0.009979:0.006652:0.009676:0.004233:0.009979:0.009676:0.003931:0.003931:0.009071:0.003629:0.004536:0.003629:0.009676:0.009071:0.006652:0.004233:0.004233:0.009676:0.004838:0.004233:0.004233:0.008769:0.004233:0.007862:0.004233:0.003629:0.009071:0.004233:0.009979:0.009676:0.009071:0.009676:0.004838:0.009979:0.003629:0.004233:0.009979:0.009071:0.009979:0.004233:0.004233:0.009676:0.004838:0.004233:0.006350:0.008769:0.004233:0.004233:0.008769:0.004233:0.007862
General case definition for IRIS – Shelburne :@0.082070:0.647337:0.363486:0.647337:0.363486:0.632672:0.082070:0.632672:0.011289:0.008601:0.008063:0.008601:0.004301:0.008870:0.003225:0.003763:0.008601:0.008870:0.005913:0.008601:0.003763:0.008870:0.008601:0.003494:0.003494:0.008063:0.003225:0.004032:0.003225:0.008601:0.008063:0.003763:0.003763:0.008601:0.004301:0.003763:0.003763:0.007795:0.003763:0.006988:0.003763:0.006720:0.003763:0.006988:0.008063:0.008601:0.003225:0.008870:0.008063:0.004301:0.008063:0.008601:0.003763
et al.:@0.363459:0.647337:0.395713:0.647337:0.395713:0.632672:0.363459:0.632672:0.008601:0.004032:0.003763:0.008870:0.003225:0.003763
12:@0.395705:0.642627:0.404435:0.642627:0.404435:0.634121:0.395705:0.634121:0.004365:0.004365
Case definition for paradoxical TB IRIS – Meintjes:@0.460466:0.647337:0.773329:0.647337:0.773329:0.632672:0.460466:0.632672:0.010483:0.008870:0.005913:0.008601:0.003763:0.008870:0.008601:0.003494:0.003494:0.008063:0.003225:0.004032:0.003225:0.008601:0.008063:0.003763:0.003763:0.008601:0.004301:0.003763:0.008870:0.008870:0.004301:0.008870:0.008870:0.008601:0.007526:0.003225:0.008601:0.008870:0.003225:0.003763:0.005644:0.007795:0.003763:0.003763:0.007795:0.003763:0.006988:0.003763:0.006720:0.003763:0.012095:0.008601:0.003225:0.008063:0.004032:0.003494:0.008601:0.005913
 et al.:@0.773289:0.647337:0.809306:0.647337:0.809306:0.632672:0.773289:0.632672:0.003763:0.008601:0.004032:0.003763:0.008870:0.003225:0.003763
9:@0.809300:0.642627:0.813665:0.642627:0.813665:0.634121:0.809300:0.634121:0.004365
HIV-infected patient:@0.082070:0.662731:0.214016:0.662731:0.214016:0.648702:0.082070:0.648702:0.009179:0.003037:0.009434:0.004462:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.008735:0.009206:0.003723:0.009165:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556
TB adequately diagnosed and good initial response to TB treatment:@0.460463:0.662731:0.899694:0.662731:0.899694:0.648702:0.460463:0.648702:0.005725:0.007714:0.003723:0.009179:0.009206:0.008735:0.009165:0.008171:0.009179:0.004556:0.008735:0.002688:0.007203:0.003723:0.009206:0.002688:0.009179:0.009045:0.008198:0.008803:0.005214:0.008735:0.009206:0.003723:0.009179:0.008198:0.009206:0.003723:0.009045:0.008803:0.008803:0.009206:0.003723:0.002688:0.008198:0.002688:0.004556:0.002688:0.009179:0.002688:0.003723:0.004045:0.008735:0.005214:0.009165:0.008803:0.008198:0.005214:0.008735:0.003723:0.004556:0.008803:0.003723:0.005725:0.007714:0.003723:0.004556:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556
Receiving effective ART as evidenced by a decrease in :@0.082070:0.678125:0.446835:0.678125:0.446835:0.664096:0.082070:0.664096:0.008158:0.008735:0.008695:0.008735:0.002688:0.007445:0.002688:0.008198:0.009045:0.003723:0.008735:0.004220:0.004220:0.008735:0.008695:0.004556:0.002688:0.007445:0.008735:0.003723:0.009945:0.008158:0.005725:0.003723:0.009179:0.005214:0.003723:0.008735:0.007445:0.002688:0.009206:0.008735:0.008198:0.008695:0.008735:0.009206:0.003723:0.009165:0.007203:0.003723:0.009179:0.003723:0.009206:0.008735:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.003723:0.002688:0.008198:0.003723
HIV-1 RNA concentration from baseline or an increase in  because of treatment failure:@0.082070:0.690953:0.647441:0.690953:0.647441:0.676924:0.082070:0.676924:0.009179:0.003037:0.009434:0.004462:0.007445:0.003723:0.008158:0.009945:0.009945:0.003723:0.008695:0.008803:0.008198:0.008695:0.008735:0.008198:0.004556:0.004045:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.004220:0.004045:0.008803:0.012606:0.003723:0.009165:0.009179:0.005214:0.008735:0.002688:0.002688:0.008198:0.008735:0.003723:0.008803:0.004045:0.003723:0.009179:0.008198:0.003723:0.002688:0.008198:0.008695:0.004045:0.008735:0.009179:0.005214:0.008735:0.003723:0.002688:0.008198:0.003723:0.009058:0.009165:0.008735:0.008695:0.009179:0.008171:0.005214:0.008735:0.003723:0.008803:0.004220:0.003723:0.004556:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556:0.003723:0.004220:0.009179:0.002688:0.002688:0.008171:0.004045:0.008735
CD4+ T cells from baseline:@0.082070:0.703782:0.251497:0.703782:0.251497:0.689753:0.082070:0.689753:0.010926:0.009999:0.007445:0.008144:0.003723:0.005725:0.003723:0.008695:0.008735:0.002688:0.002688:0.005214:0.003723:0.004220:0.004045:0.008803:0.012606:0.003723:0.009165:0.009179:0.005214:0.008735:0.002688:0.002688:0.008198:0.008735
Onset within 3 months or ART initiation, re-initiation, or regimen change :@0.460463:0.678125:0.921103:0.678125:0.921103:0.664096:0.460463:0.664096:0.011679:0.008198:0.005214:0.008735:0.004556:0.003723:0.011168:0.002688:0.004556:0.008198:0.002688:0.008198:0.003723:0.007445:0.003723:0.012606:0.008803:0.008198:0.004556:0.008198:0.005214:0.003723:0.008803:0.004045:0.003723:0.009945:0.008158:0.005725:0.003723:0.002688:0.008198:0.002688:0.004556:0.002688:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.004045:0.008735:0.004462:0.002688:0.008198:0.002688:0.004556:0.002688:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.008803:0.004045:0.003723:0.004045:0.008735:0.009045:0.002688:0.012606:0.008735:0.008198:0.003723:0.008695:0.008198:0.009179:0.008198:0.009045:0.008735:0.003723
Clinical symptoms consistent with the inflammatory :@0.082070:0.719176:0.416060:0.719176:0.416060:0.705147:0.082070:0.705147:0.010926:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214:0.003723:0.008695:0.008803:0.008198:0.005214:0.002688:0.005214:0.004556:0.008735:0.008198:0.004556:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.004556:0.008198:0.008735:0.003723:0.002688:0.008198:0.003259:0.003259:0.009179:0.012606:0.012606:0.009179:0.004556:0.008803:0.004045:0.007203:0.003723
process:@0.082070:0.732004:0.131943:0.732004:0.131943:0.717975:0.082070:0.717975:0.009165:0.004045:0.008803:0.008695:0.008735:0.005214:0.005214
One major clinical criterion or two minor clinical criteria::@0.460466:0.719176:0.821777:0.719176:0.821777:0.705147:0.460466:0.705147:0.011679:0.008198:0.008735:0.003723:0.012606:0.009179:0.002728:0.008803:0.004045:0.003723:0.008695:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.003723:0.008695:0.004045:0.002688:0.004556:0.008735:0.004045:0.002688:0.008803:0.008198:0.003723:0.008803:0.004045:0.003723:0.004556:0.011168:0.008803:0.003723:0.012606:0.002688:0.008198:0.008803:0.004045:0.003723:0.008695:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.003723:0.008695:0.004045:0.002688:0.004556:0.008735:0.004045:0.002688:0.009179:0.003723
Major criteria::@0.500783:0.732004:0.589965:0.732004:0.589965:0.717975:0.500783:0.717975:0.012351:0.009179:0.002728:0.008803:0.004045:0.003723:0.008695:0.004045:0.002688:0.004556:0.008735:0.004045:0.002688:0.009179:0.003723
• :@0.480625:0.743939:0.490166:0.743939:0.490166:0.731368:0.480625:0.731368:0.006182:0.003360
New or enlarging lymph nodes, cold abscesses, or focal tissue :@0.500783:0.744832:0.905759:0.744832:0.905759:0.730803:0.500783:0.730803:0.009945:0.008735:0.011168:0.003723:0.008803:0.004045:0.003723:0.008735:0.008198:0.002688:0.009179:0.004045:0.009045:0.002688:0.008198:0.009045:0.003723:0.002688:0.007203:0.012606:0.009165:0.008198:0.003723:0.008198:0.008803:0.009206:0.008735:0.005214:0.003723:0.003723:0.008695:0.008803:0.002688:0.009206:0.003723:0.009179:0.009165:0.005214:0.008695:0.008735:0.005214:0.005214:0.008735:0.005214:0.003723:0.003723:0.008803:0.004045:0.003723:0.004220:0.008803:0.008695:0.009179:0.002688:0.003723:0.004556:0.002688:0.005214:0.005214:0.008171:0.008735:0.003723
involvement:@0.500783:0.757660:0.580881:0.757660:0.580881:0.743631:0.500783:0.743631:0.002688:0.008198:0.007445:0.008803:0.002688:0.007445:0.008735:0.012606:0.008735:0.008198:0.004556
• :@0.480625:0.769596:0.490166:0.769596:0.490166:0.757024:0.480625:0.757024:0.006182:0.003360
New or worsening radiological features of TB:@0.500783:0.770489:0.788932:0.770489:0.788932:0.756460:0.500783:0.756460:0.009945:0.008735:0.011168:0.003723:0.008803:0.004045:0.003723:0.011168:0.008803:0.004045:0.005214:0.008735:0.008198:0.002688:0.008198:0.009045:0.003723:0.004045:0.009179:0.009206:0.002688:0.008803:0.002688:0.008803:0.009045:0.002688:0.008695:0.009179:0.002688:0.003723:0.004220:0.008735:0.009179:0.004556:0.008171:0.004045:0.008735:0.005214:0.003723:0.008803:0.004220:0.003723:0.005725:0.007714
• :@0.480625:0.782424:0.490166:0.782424:0.490166:0.769852:0.480625:0.769852:0.006182:0.003360
New or worsening CNs TB:@0.500783:0.783317:0.665467:0.783317:0.665467:0.769288:0.500783:0.769288:0.009945:0.008735:0.011168:0.003723:0.008803:0.004045:0.003723:0.011168:0.008803:0.004045:0.005214:0.008735:0.008198:0.002688:0.008198:0.009045:0.003723:0.010926:0.009945:0.006693:0.003723:0.005725:0.007714
• :@0.480625:0.795252:0.490166:0.795252:0.490166:0.782681:0.480625:0.782681:0.006182:0.003360
New or worsening serositis:@0.500783:0.796145:0.667899:0.796145:0.667899:0.782116:0.500783:0.782116:0.009945:0.008735:0.011168:0.003723:0.008803:0.004045:0.003723:0.011168:0.008803:0.004045:0.005214:0.008735:0.008198:0.002688:0.008198:0.009045:0.003723:0.005214:0.008735:0.004045:0.008803:0.005214:0.002688:0.004556:0.002688:0.005214
Minor criteria::@0.500783:0.808974:0.588944:0.808974:0.588944:0.794945:0.500783:0.794945:0.012351:0.002688:0.008198:0.008803:0.004045:0.003723:0.008695:0.004045:0.002688:0.004556:0.008735:0.004045:0.002688:0.009179:0.003723
• :@0.482305:0.820909:0.491846:0.820909:0.491846:0.808337:0.482305:0.808337:0.006182:0.003360
New or worsening constitutional symptoms:@0.500783:0.821802:0.776823:0.821802:0.776823:0.807773:0.500783:0.807773:0.009945:0.008735:0.011168:0.003723:0.008803:0.004045:0.003723:0.011168:0.008803:0.004045:0.005214:0.008735:0.008198:0.002688:0.008198:0.009045:0.003723:0.008695:0.008803:0.008198:0.005214:0.004556:0.002688:0.004556:0.008171:0.004556:0.002688:0.008803:0.008198:0.009179:0.002688:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214
• :@0.482305:0.833737:0.491846:0.833737:0.491846:0.821166:0.482305:0.821166:0.006182:0.003360
New or worsening respiratory symptoms:@0.500783:0.834630:0.757511:0.834630:0.757511:0.820601:0.500783:0.820601:0.009945:0.008735:0.011168:0.003723:0.008803:0.004045:0.003723:0.011168:0.008803:0.004045:0.005214:0.008735:0.008198:0.002688:0.008198:0.009045:0.003723:0.004045:0.008735:0.005214:0.009165:0.002688:0.004045:0.009179:0.004556:0.008803:0.004045:0.007203:0.003723:0.005214:0.007203:0.012606:0.009165:0.004556:0.008803:0.012606:0.005214
• :@0.482305:0.846565:0.491846:0.846565:0.491846:0.833994:0.482305:0.833994:0.006182:0.003360
New or worsening abdominal pain accompanied by peritonitis, :@0.500783:0.847458:0.916873:0.847458:0.916873:0.833429:0.500783:0.833429:0.009945:0.008735:0.011168:0.003723:0.008803:0.004045:0.003723:0.011168:0.008803:0.004045:0.005214:0.008735:0.008198:0.002688:0.008198:0.009045:0.003723:0.009179:0.009165:0.009206:0.008803:0.012606:0.002688:0.008198:0.009179:0.002688:0.003723:0.009165:0.009179:0.002688:0.008198:0.003723:0.009179:0.008695:0.008695:0.008803:0.012606:0.009165:0.009179:0.008198:0.002688:0.008735:0.009206:0.003723:0.009165:0.007203:0.003723:0.009165:0.008735:0.004045:0.002688:0.004556:0.008803:0.008198:0.002688:0.004556:0.002688:0.005214:0.003723:0.003723
hepatomegaly, splenomegaly or abdominal adenopathy.:@0.500783:0.860287:0.880453:0.860287:0.880453:0.846258:0.500783:0.846258:0.008198:0.008735:0.009165:0.009179:0.004556:0.008803:0.012606:0.008735:0.009045:0.009179:0.002688:0.007203:0.003723:0.003723:0.005214:0.009165:0.002688:0.008735:0.008198:0.008803:0.012606:0.008735:0.009045:0.009179:0.002688:0.007203:0.003723:0.008803:0.004045:0.003723:0.009179:0.009165:0.009206:0.008803:0.012606:0.002688:0.008198:0.009179:0.002688:0.003723:0.009179:0.009206:0.008735:0.008198:0.008803:0.009165:0.009179:0.004556:0.008198:0.007203:0.003723
Clinical course not consistent with the expected course :@0.082073:0.875681:0.445723:0.875681:0.445723:0.861652:0.082073:0.861652:0.010926:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.003723:0.008695:0.008803:0.008171:0.004045:0.005214:0.008735:0.003723:0.008198:0.008803:0.004556:0.003723:0.008695:0.008803:0.008198:0.005214:0.002688:0.005214:0.004556:0.008735:0.008198:0.004556:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.004556:0.008198:0.008735:0.003723:0.008735:0.006451:0.009165:0.008735:0.008695:0.004556:0.008735:0.009206:0.003723:0.008695:0.008803:0.008171:0.004045:0.005214:0.008735:0.003723
of previously diagnosed opportunistic infection, expect-:@0.082073:0.888509:0.444164:0.888509:0.444164:0.874480:0.082073:0.874480:0.008803:0.004220:0.003723:0.009165:0.004045:0.008735:0.007445:0.002688:0.008803:0.008171:0.005214:0.002688:0.007203:0.003723:0.009206:0.002688:0.009179:0.009045:0.008198:0.008803:0.005214:0.008735:0.009206:0.003723:0.008803:0.009165:0.009165:0.008803:0.004045:0.004556:0.008171:0.008198:0.002688:0.005214:0.004556:0.002688:0.008695:0.003723:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.008735:0.006451:0.009165:0.008735:0.008695:0.004529:0.004462
ed course of newly diagnosed opportunistic infection, or :@0.082073:0.901337:0.452846:0.901337:0.452846:0.887308:0.082073:0.887308:0.008735:0.009206:0.003723:0.008695:0.008803:0.008171:0.004045:0.005214:0.008735:0.003723:0.008803:0.004220:0.003723:0.008198:0.008735:0.011168:0.002688:0.007203:0.003723:0.009206:0.002688:0.009179:0.009045:0.008198:0.008803:0.005214:0.008735:0.009206:0.003723:0.008803:0.009165:0.009165:0.008803:0.004045:0.004556:0.008171:0.008198:0.002688:0.005214:0.004556:0.002688:0.008695:0.003723:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723:0.003723:0.008803:0.004045:0.003723
drug toxicity:@0.082073:0.914165:0.161902:0.914165:0.161902:0.900136:0.082073:0.900136:0.009206:0.004045:0.008171:0.009045:0.003723:0.004556:0.008803:0.006451:0.002688:0.008695:0.002688:0.004556:0.007203
Alternative explanations for clinical deterioration must be excluded, if :@0.460466:0.875681:0.915583:0.875681:0.915583:0.861652:0.460466:0.861652:0.009945:0.002688:0.004556:0.008735:0.004045:0.008198:0.009179:0.004556:0.002688:0.007445:0.008735:0.003723:0.008735:0.006451:0.009165:0.002688:0.009179:0.008198:0.009179:0.004556:0.002688:0.008803:0.008198:0.005214:0.003723:0.004220:0.008803:0.004045:0.003723:0.008695:0.002688:0.002688:0.008198:0.002688:0.008695:0.009179:0.002688:0.003723:0.009206:0.008735:0.004556:0.008735:0.004045:0.002688:0.008803:0.004045:0.009179:0.004556:0.002688:0.008803:0.008198:0.003723:0.012606:0.008171:0.005214:0.004556:0.003723:0.009165:0.008735:0.003723:0.008735:0.006451:0.008695:0.002688:0.008171:0.009206:0.008735:0.009206:0.003723:0.003723:0.002688:0.004220:0.003723
possible::@0.460466:0.888509:0.515862:0.888509:0.515862:0.874480:0.460466:0.874480:0.009165:0.008803:0.005214:0.005214:0.002688:0.009165:0.002688:0.008735:0.003723
• :@0.480625:0.900444:0.490166:0.900444:0.490166:0.887873:0.480625:0.887873:0.006182:0.003360
TB drug resistance:@0.500783:0.901337:0.617395:0.901337:0.617395:0.887308:0.500783:0.887308:0.005725:0.007714:0.003723:0.009206:0.004045:0.008171:0.009045:0.003723:0.004045:0.008735:0.005214:0.002688:0.005214:0.004556:0.009179:0.008198:0.008695:0.008735
• :@0.480625:0.913273:0.490166:0.913273:0.490166:0.900701:0.480625:0.900701:0.006182:0.003360
poor adherence to TB treatment:@0.500783:0.914165:0.710972:0.914165:0.710972:0.900136:0.500783:0.900136:0.007956:0.008803:0.008803:0.004045:0.003723:0.009179:0.009206:0.008198:0.008735:0.004045:0.008735:0.008198:0.008695:0.008735:0.003723:0.004556:0.008803:0.003723:0.005725:0.007714:0.003723:0.004556:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556
• :@0.480625:0.926101:0.490166:0.926101:0.490166:0.913529:0.480625:0.913529:0.006182:0.003360
Another opportunistic infection or neoplasm:@0.500783:0.926994:0.787118:0.926994:0.787118:0.912965:0.500783:0.912965:0.009945:0.008198:0.008803:0.004556:0.008198:0.008735:0.004045:0.003723:0.008803:0.009165:0.009165:0.008803:0.004045:0.004556:0.008171:0.008198:0.002688:0.005214:0.004556:0.002688:0.008695:0.003723:0.002688:0.008198:0.004220:0.008735:0.008695:0.004556:0.002688:0.008803:0.008198:0.003723:0.008803:0.004045:0.003723:0.008198:0.008735:0.008803:0.009165:0.002688:0.009179:0.005214:0.012606
• :@0.480625:0.938929:0.490166:0.938929:0.490166:0.926357:0.480625:0.926357:0.006182:0.003360
Drug toxicity or reaction:@0.500783:0.939822:0.656597:0.939822:0.656597:0.925793:0.500783:0.925793:0.009999:0.004045:0.008171:0.009045:0.003723:0.004556:0.008803:0.006451:0.002688:0.008695:0.002688:0.004556:0.007203:0.003723:0.008803:0.004045:0.003723:0.004045:0.008735:0.009179:0.008695:0.004556:0.002688:0.008803:0.008198